ACA
MDT icon

Arsenal Capital Advisors’s Medtronic MDT Stock Holding History

Arsenal Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Sell
3,389
-73
-2% -$5.89K 0.16% 94
2026
Q1 		$302K Buy
3,462
+21
+0.6% +$2.01K 0.22% 76
2025
Q4 		$333K Buy
+3,441
New +$334K 0.24% 71

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Arsenal Capital Advisors's MDT Position: Q2 2026 in Review

Arsenal Capital Advisors reduced its Medtronic (MDT) stake by 2.1% in Q2 2026, selling an estimated $5.89K and leaving 3,389 shares worth $265K. The position accounts for 0.16% of the portfolio, ranked #94.

Arsenal Capital Advisors first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $333K in Q4 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Arsenal Capital Advisors held 3,389 shares of Medtronic worth $265K as of Q2 2026.
  • Arsenal Capital Advisors sold 73 Medtronic shares in Q2 2026, an estimated $5.89K.
  • Medtronic made up 0.16% of Arsenal Capital Advisors's portfolio in Q2 2026, its #94 holding.
  • Arsenal Capital Advisors first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Arsenal Capital Advisors's Medtronic position peaked at $333K in Q4 2025.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Arsenal Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.